Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use - Wikidata - awgldk - TriplyDB

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

http://www.wikidata.org/entity/Q28473574

about

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain Bridging the gap between education and appropriate use of benzodiazepines in psychiatric clinical practice Off-label use of sodium valproate for schizophrenia A translational research approach to poor treatment response in patients with schizophrenia: clozapine-antipsychotic polypharmacy Antipsychotic polypharmacy in a regional health service: a population-based study.Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptor.Treatment-resistant Schizophrenia: Evidence-based Strategies Pharmacotherapy for treatment-refractory schizophrenia.Description of long-term polypharmacy among schizophrenia outpatients.Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.Analysis of the Health Insurance Review and Assessment Service data from 2011 to 2015.Changes in antipsychotic drug usage and factors affecting the use of typical drugs based on nationwide health insurance data in South Korea.Polypharmazie bei schizophrenen Psychosen

P2860

Q21561008-245C5255-5AFC-4AF8-BB25-274FEDBBA4A9 Q26800235-93348C79-B817-417A-B9E7-C63A42C012C3 Q28541404-3D4A488D-3396-4EF6-A5B7-F3540BD724F7 Q30485065-CA6B504E-D2E5-47CA-AED6-CAD6AEACAABC Q34269517-1DD69F36-F1A2-4D35-862F-1D658DEAD62F Q34376884-869E3500-46DF-402C-A0CD-B4591EFAC277 Q35964353-04BEF56D-5B11-435D-A9A2-3B1C50BC4411 Q37831352-0AA283D4-3AB0-478C-9E3B-901B69513DBB Q44057877-77A69F35-9935-45B9-BE12-09AC57F9769E Q46145089-6AB82850-9D9D-4A8F-97AB-44EA9BD089DB Q52673029-5ED14B23-B24A-45BA-AB0E-90548453C5C5 Q55645530-37C155CA-F64A-4A7A-AB10-E5B7639A7132 Q57317032-B3646675-BB9C-4208-B3D1-9619A3DA0B8F

P2860

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

http://www.wikidata.org/entity/Q28473574

description

2008 nî lūn-bûn

@nan

2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@ast

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@en

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@nl

type

label

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@ast

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@en

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@nl

prefLabel

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@ast

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@en

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@nl

P1433

Q28473574-DA32DE2C-72ED-4A86-BE96-7B2638F52DB5

P1476

Q28473574-517AF19B-06CA-42E7-9AED-E015DE6C79A4

P2093

Q28473574-0266C25C-A678-4D7F-908A-72967A09EDC3

Q28473574-096B6291-5936-411F-8C72-4448C3B57B93

Q28473574-FB82098B-5A33-4C7F-A109-72DC74C2B522

P2860

Q28473574-08FB6AF1-59D6-474D-AD64-AB5A04E8A991

Q28473574-11DC84E9-2B2C-4808-9337-BB68C813F9AE

Q28473574-17B90070-583B-44CE-872D-235D10E21DC9

Q28473574-293AC920-4068-4A90-A04B-150287492A6F

Q28473574-2EC6B753-A36A-4A7F-8BC4-01F3E9947350

Q28473574-36C27B47-8C0D-4F71-B55C-E7B50E05A9E1

Q28473574-3B1A6BD7-DDD0-4D38-9065-0845A6446C35

Q28473574-4EA9B206-2D2C-4E15-BA8C-1F5B5846025E

Q28473574-5121BA34-962F-42C7-ACCE-0C0F4EF71FAA

Q28473574-53F6F14A-91EA-48F3-968A-2DBF5207593E

P304

Q28473574-7F28292C-73FC-4B1B-9A74-CD78F336D41D

P31

Q28473574-CE3D67F2-DB31-4AE3-955E-4674127640F9

P356

Q28473574-10C984E3-7416-4FA2-A18D-C59CEF81516D

P407

Q28473574-B91A5F61-67FE-4643-A2F7-6F694AAF672C

P433

Q28473574-215EA9A3-7CEA-4F15-A1BD-133687408B6C

P478

Q28473574-C7820FC5-7407-44AD-BCFA-A6E851E3F037

P577

Q28473574-9859741D-5A91-422D-AA33-A6D1BC3FDF3E

P5875

Q28473574-E6317988-118B-4D45-85C8-E88F08D1BF30

P698

Q28473574-A28351F7-D334-4BCD-81A6-E231C79E0AC4

P921

Q28473574-2BCCCA0C-F9B1-4F0C-8C39-A4CE9A10053B

Q28473574-B5E777DB-0423-475C-834F-E990D77ED53C

P932

Q28473574-761A8D2E-825F-4B0E-9378-74F21D83BBD1

P356

JOURNAL.PONE.0003150

P1433

P1476

Pharmacotherapy of schizophrenic patients: preponderance of off-label drug use

@en

P2093

David Pickar

http://www.w3.org/2001/XMLSchema#string

Jessie Vinik

http://www.w3.org/2001/XMLSchema#string

John J Bartko

http://www.w3.org/2001/XMLSchema#string

P2860

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

The positive and negative syndrome scale (PANSS) for schizophrenia

A new depression scale designed to be sensitive to change

Depression in schizophrenia: perspective in the era of "Atypical" antipsychotic agents.

Effect of divalproex combined with olanzapine or risperidone in patients with an acute exacerbation of schizophrenia.

Introduction to the special section on CATIE baseline data: practical clinical trials in psychiatry: studies of schizophrenia from the CATIE network.

Treatment of schizoaffective disorder and schizophrenia with mood symptoms.

Off-label prescribing among office-based physicians.

A meta-analysis of the efficacy of second-generation antipsychotics.

Narrative review: the promotion of gabapentin: an analysis of internal industry documents.

P304

e3150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0003150

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2008-09-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23246952

http://www.w3.org/2001/XMLSchema#string

P698

18781198

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy

P932

2522284

http://www.w3.org/2001/XMLSchema#string